The
following potentially dilutive shares of common stock equivalents on an “as-converted basis” were excluded from the computation
of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:
Schedule of Potentially Dilutive Shares Excluded from Computation of Net Loss Per Share
| | |
December 31, | |
| | |
2024 | | |
2023 | |
| | |
(per share data) | |
| Common stock warrants | |
| 215,134 | | |
| 97,039 | |
| Restricted stock units | |
| 38,028 | | |
| 38,222 | |
| Common stock options | |
| 18,036 | | |
| 25,053 | |
| Total potentially dilutive common share equivalents | |
| 271,198 | | |
| 160,314 | |
|